Triatomic Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Elegenelegenbio.comin𝕏May 2024
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)
BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)
Co-investorsACVC PartnersAndreessen HorowitzRaptor GroupAME Cloud VenturesDigitalis VenturesIn-Q-Tel+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.